Patents by Inventor Hyun-Nam Song

Hyun-Nam Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
    Patent number: 10239902
    Abstract: The present invention provides a stable peptide-conjugated, ascorbic acid derivative, a method for preparing the same, and a cosmetic composition comprising the same as an active ingredient. The stable peptide-conjugated ascorbic acid derivative of the present invention has both the effect of whitening the skin by inhibiting melanin production and the effect of reducing skin wrinkles by activating collagen production, and may be used in a cosmetic composition.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: March 26, 2019
    Assignee: CELLTRION INC.
    Inventors: Young Jun Park, Jung Yun Kim, Jin Kyo Jeong, Hyeong Mi Kim, Eun Joo Cho, Joo Hyuck Lim, Hyun Nam Song, Seon Kyung Park, Won Kang Moon, Shin Jae Chang, Seung Suh Hong
  • STABLE PEPTIDE-CONJUGATED ASCORBIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME
    Publication number: 20170258931
    Abstract: The present invention provides a stable peptide-conjugated, ascorbic acid derivative, a method for preparing the same, and a cosmetic composition comprising the same as an active ingredient. The stable peptide-conjugated ascorbic acid derivative of the present invention has both the effect of whitening the skin by inhibiting melanin production and the effect of reducing skin wrinkles by activating collagen production, and may be used in a cosmetic composition.
    Type: Application
    Filed: May 26, 2017
    Publication date: September 14, 2017
    Applicant: CELLTRION INC.
    Inventors: Young Jun Park, Jung Yun Kim, Jin Kyo Jeong, Hyeong Mi Kim, Eun Joo Cho, Joo Hyuck Lim, Hyun Nam Song, Seon Kyung Park, Won Kang Moon, Shin Jae Chang, Seung Suh Hong
  • Piperazine dithioctate and pharmaceutical composition comprising the same
    Patent number: 8541601
    Abstract: The present invention relates to piperazine dithioctate, a novel addition salt of thioctic acid with a base and a pharmaceutical composition comprising the same. The piperazine dithioctate according to the present invention has good thermal and moisture stability and high water-solubility as well as dosage increase lower than other addition salts, thereby being effectively used for preparing a pharmaceutical composition for antioxidation or for preventing or treating diabetic polyneuropathy, etc.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: September 24, 2013
    Assignees: Celltrion Chemical Research Institute, Celltrion Pharm, Inc.
    Inventors: Kyoung Soo Kim, Young Jun Park, Hyun-Nam Song, In Suk Lee, Joon Woo Kim
  • IMATINIB DICHLOROACETATE AND ANTI-CANCER AGENT COMPRISING THE SAME
    Publication number: 20120295917
    Abstract: The present invention relates to imatinib dichloroacetate and an anti-cancer agent comprising the same. The imatinib dichloroacetate of the present invention can inhibit tyrosine kinase as well as induce cancer cells to kill themselves via apoptosis, thereby inhibit growth of cancer cells and lead to their destruction, and show significantly enhanced anti-cancer effects by synergy between imatinib and dichloroacetic acid.
    Type: Application
    Filed: December 28, 2010
    Publication date: November 22, 2012
    Applicants: CELLTRION PHARM, INC., CELLTRION CHEMICAL RESEARCH INSTITUTE
    Inventors: Kyoung Soo Kim, Young Jun Park, Hyun-Nam Song, Joon Woo Kim
  • PIPERAZINE DITHIOCTATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20120101107
    Abstract: The present invention relates to piperazine dithioctate, a novel addition salt of thioctic acid with a base and a pharmaceutical composition comprising the same. The piperazine dithioctate according to the present invention has good thermal and moisture stability and high water-solubility as well as dosage increase lower than other addition salts, thereby being effectively used for preparing a pharmaceutical composition for antioxidation or for preventing or treating diabetic polyneuropathy, etc.
    Type: Application
    Filed: June 18, 2010
    Publication date: April 26, 2012
    Applicants: CELLTRION PHARM, INC., CELLTRION CHEMICAL RESEARCH INSTITUTE
    Inventors: Kyoung Soo Kim, Young Jun Park, Hyun-Nam Song, In Suk Lee, Joon Woo Kim